Charles River Laboratories (CRL) Tops Q3 EPS by 15c
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $285.11 +2.19%
Revenue Growth %: -4.2%
Financial Fact:
Cost of products sold: 69.33M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: -4.2%
Financial Fact:
Cost of products sold: 69.33M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q3 EPS of $1.53, $0.15 better than the analyst estimate of $1.38. Revenue for the quarter came in at $585.3 million versus the consensus estimate of $567.79 million.
GUIDANCE:
Charles River Laboratories sees FY2018 EPS of $5.87-$5.97, versus the consensus of $5.92.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- AutoZone beats profit view but misses on revenue
- AutoZone (AZO) Tops Q4 EPS by $1.76, Misses on Revenue
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
